Page results
-
POEMS syndrome is a rare condition caused by the body producing abnormal plasma cells (a type of blood cell which produces antibodies to fight off infections).
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
Here you find all of our information leaflets which will help with day to day diabetes management including managing highs and lows, sick day rules and managing school days including the most up to date school care plans. You will also find information on how to upload your devices at home.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
UCLH and UCL researchers have successfully completed a world-first trial of a therapy designed to restore hearing loss.
-
Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.
-
An online exhibition by Dr Sarah Yardley and artist Daniel Regan, exploring the role of relationships and relationship-centred approaches to healthcare.
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
File results
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0648 - Performance management Policy for July 2020 to November 2022
-
FOI/2024/0651 - Family history units/ familial cancer services
-
FOI/2024/0652 - Overseas visitors invoiced in 2023/24
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0663 - Diagnosis discharge codes and cases 2018-19 to 2022-23
-
FOI/2024/0667 - Agency/ bank staff, master/neutral vendor/ contract and contact details 2023/24
-
FOI/2024/0668 - Doctors shifts covered by Physician Associates 01/04/2024-01/09/2024
-
FOI/2024/0675 - Direct engagement agency usage/ spend for doctors, nursing and AHP/HSS
-
FOI/2024/0680 - MSP-MV recruitment solution/ contract/ annual spend/ contact details